Reminder: Innospec Inc. Fourth Quarter and Full Year 2005 Conference Call
03 Fevereiro 2006 - 3:54PM
Business Wire
Innospec Inc. (NYSE: IOP), formerly Octel Corp., an international
chemical company specializing in the manufacture, distribution and
marketing of fuel additives and specialty chemicals, issued a
reminder that the company will report fourth quarter and full year
2005 results on Monday, February 6, 2006, after the close of the
market. Following the release of its results, the company will host
a conference call for the investment community on Tuesday, February
7th. Hosting the call will be Paul Jennings, President and Chief
Executive Officer, and Jim Lawler, Executive Vice President and
Chief Financial Officer of Innospec Inc. The call will begin
promptly at 8:30 A.M. EST and can be accessed using the dial-in
numbers 1 (800) 370-0923 (toll free) or 1 (973) 409-9261
(international) or via a simultaneous webcast on the company
website www.innospecinc.com. The webcast and audio replay will be
available beginning at 11:30 A.M. EST on February 7th until
midnight on February 21st. The replay numbers are 1 (877) 519-4471
(toll free) and 1 (973) 341-3080 (international), conference ID #
6893805. About Innospec Inc. Innospec Inc., a Delaware corporation,
is an international specialty chemical company focused on providing
unique and value added solutions in the fuel additives and
performance chemicals markets. The Company's operations divide into
three distinct businesses - Fuel Specialties, Performance Chemicals
and Octane Additives. Innospec employs almost 1,000 people in 21
countries with manufacturing bases in many countries and a
worldwide distribution network already in place. The business had
annual revenues in excess of $450 million in fiscal year 2004.
Innospec (NYSE:IOP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Innospec (NYSE:IOP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Innospec Inc. da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Innospec Inc.